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Myocardial ﬁbrosisDuchenne muscular dystrophy (DMD) is an X-linked hereditary
muscular disorder that leads to degeneration and atrophy of
skeletal and cardiac muscle. Skeletal muscle disease causes limb
muscle weakness, with loss of ambulation at the ages of around
10 years or less. The majority of DMD patients develop dilated
cardiomyopathy in their mid-teens, characterized by enlarged
heart chambers and reduced cardiac wall thickness. On the other
hand, intercostal and diaphragmatic respiratory muscle weakness
and scoliosis leads to respiratory problems that force DMD patients
to use respiratory devices. The cardiomyopathy emphasizes
respiratory problems, and the DMD patient dies from cardiac
and/or respiratory failure typically by 30 years of age [1].
Echocardiography is a noninvasive method of evaluating left
ventricular (LV) size and systolic function to assess cardiac
involvement in DMD patients, but is usually obtained after the
onset of heart failure symptoms. Unfortunately, myocardial
damage after the symptom onset with overt LV dysfunction
may be irreversible and progressive, ending in death. Thus, earlier
referral by some other methodology that identiﬁes earlier
disease is required [2]. Current treatment options are limited to
glucocorticoids that produce inconsistent effects on myocardial
disease. However, several studies have demonstrated that use of
angiotensin-converting enzyme inhibitors, beta blockers, and
aldosterone antagonists in patients with DMD reverse congestive
heart failure signs and symptoms, delay progression of LV
dysfunction, and improve systolic function [3]. If these treatments
are initiated earlier, more beneﬁcial effects may be potentially
gained. Thus, earlier detection of subclinical myocardial disease
and earlier initiation of these treatments may be necessary in DMD
patients. End-stage cardiac pathology consists of alternating areasDOI of original article: http://dx.doi.org/10.1016/j.jjcc.2015.02.003
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0914-5087/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsof myocyte hypertrophy, atrophy, and ﬁbrosis [4]. On the other
hand, myocardial ﬁbrosis is initially localized to LV posterior wall
(LVPW) [5,6], so that it should be a key issue to detect myocardial
ﬁbrosis in LVPW for early detection of subclinical myocardial
disease in DMD patients.
In this issue of the Journal of Cardiology, Yamamoto et al.
describe the usefulness of analyzing transmural myocardial strain
proﬁle (TMSP) with passive leg lifting in predicting subclinical LV
dysfunction in DMD patients [7]. They used tissue Doppler-based
radial strain for TMSP analysis. They have previously published
another article presenting the utility of the TMSP analysis at rest in
DMD patients [8]. In this previous article, they showed that a TMSP
pattern with a notch can predict prevalence of wall motion
abnormality at 1-year follow-up in LVPW with originally normal
contraction in DMD patients. The results are wonderful, and their
method may be a promising tool to detect early myocardial disease
in DMD patients. However, the etiology of the notch formation is
unclear. They deﬁned TMSP with a notch as the presence of an
intra-myocardial descent between 2 peaks in the TMSP curve. In
example pictures in their articles, it looks like the intra-myocardial
descents locate in the epicardial half of LVPW. So, it can be
speculated that this epicardial descent of the TMSP curve is the real
essence of the abnormal sign because ﬁbrosis begins in the outer
half of the myocardium, especially in the LVPW in DMD patients
[9]. It can be supposed that a descent of the TMSP curve in the outer
half myocardium represents reduced radial strain of ﬁbrotic layer
in the epicardial side of LVPW. Viewed in this light, it appears
reasonable that TMSP with a notch is predictive of the future
presence of LVPW motion abnormality and is an early sign of
subclinical myocardial disease. Previous studies have shown
similar data consistent with this speculation [10,11]. In those
cross-sectional studies where tissue Doppler-based strain analyses
were also performed, a positive strain value in the inner layer and a
negative strain value in the outer layer were simultaneously
observed in LVPW of a substantial proportion of DMD patients. The
previous and the current studies by Yamamoto et al. additionally
provided important information about changes in wall motion of
myocardium with such a biphasic TMSP pattern. The results are
superb but further solution of the etiology is needed. Comparison
of an echocardiographic TMSP analysis with other modalities,
e.g. cardiac magnetic resonance with late gadolinium enhance-
ment, may provide a clue to the etiology of TMSP with a notch.
Also, TMSP had better be examined in various cardiomyopathies reserved.
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relationship between ﬁbrosis distributions and TMSP patterns.
In their current paper published in this issue, Yamamoto et al.
describe that TMSP with a notch persisting from rest to leg lifting
stress is more accurately predictive of the presence of LVPW motion
abnormality at 1-year follow-up, whereas presence of TMSP with a
notch either at rest or during stress is predictive of the absence of
LVPW motion abnormality. They speculate that increased preload by
passive leg-lifting results in an increased peak strain value without
changes in transmural strain distribution in normal myocardium
according to Frank-Starling mechanism, but, to the contrary, the
persisting TMSP with a notch at rest and during passive leg-lifting
may reﬂect the presence of subclinical myocardial disease. It is
reasonable. However, what about patients with appearance of TMSP
with a notch during leg-lifting despite normal TMSP at rest, or what
about patients with disappearance of TMSP with a notch during leg-
lifting? It is left unanswered, but is probably a matter of degree.
Temporal TMSP abnormality either at rest or during leg-lifting
may be seen in patients with slighter myocardial ﬁbrosis than in
patients with persisting TMSP abnormality. It can be supposed that
LV systolic dysfunction will be present much later also in patients
with the temporal TMSP abnormality despite the absence of
signiﬁcant LV systolic dysfunction at 1-year follow-up. Future
studies with much longer follow-up periods will be needed to
address whether this speculation is correct or not.
There have been also other previous studies that tried to detect
subclinical myocardial damage in DMD patients. Some studies used
cardiac magnetic resonance but the others used echocardiography.
In those cross-sectional echocardiographic studies, strain or strain
rate of circumferential and/or radial directions was examined to
detect subclinical myocardial damage in DMD patients [12,13]. In
contrast, the present study by Yamamoto et al. was unique in terms
that they analyzed TMSP with a more sophisticated tissue Doppler
imaging method and they prospectively investigated time course of
wall motion in myocardium with abnormal TMSP patterns.
Hopefully, great efforts of these earnest researchers will lead to
earlier detection of subclinical myocardial disease in DMD patients,
and will help to improve prognoses in DMD patients.
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